Interactive Decision Support Tool

Share

Program Content

Activities

  • (Neo) Adjuvant Tx HER2-Negative EBC
    (Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 06, 2022

    Expires: September 05, 2023

Faculty

cover img faculity

Denise A. Yardley, MD

Senior Investigator
Breast Cancer Research Program
The Sarah Cannon Research Institute and Tennessee Oncology
Nashville, Tennessee

cover img faculity

Jame Abraham, MD, FACP

Chairman
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Tiffany A. Traina, MD

Assistant Attending
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Assistant Professor
Department of Medicine
Weill Medical College of Cornell University
New York, New York

Provided by

ProCE Banner

Supporters

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Partners

Smart Patients

ProCE Banner